PAPER Burns AP, Fortel I, Zhan L, Lazarov O, Mackin RS, Demos AP, Bendlin B, Leow A

Longitudinal excitation-inhibition balance altered by sex and APOE-ε4.

Commun Biol. 2025 Mar 25;8(1):488. PubMed.

PAPER Santos LE, Mattos P, Pinheiro TL, Silva A, Drummond C, Sudo FK, Barros-Aragão F, Vanderborght B, Brandão CO, Ferreira ST, IDOR Memory Clinic Initiative, Tovar-Moll F, De Felice FG

Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort.

Nat Commun. 2025 Mar 25;16(1):2911. PubMed.

PAPER Simon PY, David R

Alzheimer's disease, β-amyloid peptides and ubiquitin-proteasome system: nutritherapeutic insights.

Neurodegener Dis. 2025 Mar 25;:1-23. Epub 2025 Mar 25 PubMed.

PAPER Lim D, Matute C, Cavaliere F, Verkhratsky A

Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease.

Handb Clin Neurol. 2025;210:9-44. PubMed.

PAPER De Marchi F, Spinelli EG, Bendotti C

Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia.

Handb Clin Neurol. 2025;210:45-67. PubMed.

PAPER Hu X, Shen D, Cai H, Yan Z

The effect of rosacea on neurodegenerative and neuropsychiatric diseases: a two-sample Mendelian randomization study.

Arch Dermatol Res. 2025 Mar 27;317(1):641. PubMed.

PAPER Fernandes JV, Ramos JV, Holanda MM

Association between dapagliflozin and risk of dementia and Parkinson's disease: a subgroup analysis of a meta-analysis of randomized controlled trials.

Minerva Med. 2025 Mar 27; Epub 2025 Mar 27 PubMed.

PAPER Zhao W, Liu Z, Wu J, Liu A, Yan J

Potential targets of microglia in the treatment of neurodegenerative diseases: mechanism and therapeutic implications.

Neural Regen Res. 2025 Mar 25; Epub 2025 Mar 25 PubMed.

PAPER Wang Z, Cao W, Chen L, Zhang S, Tang L, Cui W, Kong M, Yu L, Fan D, Zheng W

The role of the peripheral immune system in mediating axonal dysfunction in early-stage amyotrophic lateral sclerosis: an age- and sex-based analysis.

Neural Regen Res. 2025 Mar 25; Epub 2025 Mar 25 PubMed.

PAPER Dzialas V, Bischof GN, Möllenhoff K, Drzezga A, van Eimeren T

Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease.

Ann Neurol. 2025 Mar 27; Epub 2025 Mar 27 PubMed.

PAPER Chen CL, Zhang MY, Wang ZL, Deng JH, Bao YP, Shi J, Lu L, Shi L

Associations among sleep quality, sleep duration, and Alzheimer's disease biomarkers: A systematic review and meta-analysis.

Alzheimers Dement. 2025 Mar;21(3):e70096. PubMed.

PAPER Lan H, Liu W, Zuo C, Chen L, Wang S, Luo C, Kuang W, Kemp GJ, Lui S, Suo X, Gong Q

Heterogeneous brain abnormalities in subjective cognitive decline converge on a common network and their transcriptional signature.

Alzheimers Dement. 2025 Mar;21(3):e70073. PubMed.

PAPER Ivain P, Baksh A, Saini F, Idris M, Tamayo-Elizalde M, Wells J, Benejam B, Loosli SV, Sandkühler K, Wlasich E, Wagemann O, Levin J, Martet D, Sacco S, Falquero S, Clert M, Rebillat AS, Khoo WM, Smith MA, Beresford-Webb J, Zaman S, Carmona-Iragui M, Videla L, Fortea J, Langballe EM, Medbøen IT, Larsen FK, Baldimtsi E, Paradisi R, Ntailakis P, Tsolaki M, Papantoniou G, McGlinchey E, McCarron M, Kennelly S, Strydom A

Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study.

Alzheimers Dement. 2025 Mar;21(3):e70071. PubMed.

PAPER Gao Y, Wang L, Doeswijk T, Winblad B, Schedin-Weiss S, Tjernberg LO

Intraneuronal Aβ accumulation causes tau hyperphosphorylation via endolysosomal leakage.

Alzheimers Dement. 2025 Mar;21(3):e70091. PubMed.

PAPER Rogalski E, Bona M, Esparza M, Fegter O, Schafer R, Mooney A, Fried-Oken M, Rademaker A, Roberts A

Efficacy of Communication Bridge-2 for primary progressive aphasia: A randomized controlled trial of communication intervention.

Alzheimers Dement. 2025 Mar;21(3):e70088. PubMed.